SecBot SecBot

BTMD

biote Corp.
Nasdaq· Medicinal Chemicals & Botanical Products· CIK 0001819253 Biotech & Drug Discovery
$1.15 +0.08 (+7.48%)
Oct 26 4:00 PM ET · prev $1.07
Market cap
$39.2M
Nano cap
Consensus
Buy
82% Buy or better · 11 analysts
Median target
$2.50
+117% · range $1.50–4.00
Next earnings
Nov 4
in 8 days · EPS est. $0.04
1 year
−60.3%
from $2.90 · Oct 27
30 days
−6.5%
from $1.23
52-week range
$1.03–2.93
−61% from high · low Oct 21
Avg volume 20D
121.8K
Oct 13 spike 387.0K
Short interest
🔒 Subscribers only
Insider net
+$202.2K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 4, 2026
Strongest NEUTRAL Amit Mohan Agarwal filed an amended Schedule 13G on 2026-09-18, reporting a passive stake of 2,400,000…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Aug 10 to Aug 11 2 days of insider buys: $202.2K by 1 insider, avg $1.53
  • X Aug 31 Short interest jumps 111.8% to 1.40M

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $202.2K at an average $1.53. No open-market sales. Price is 25% below their cost.

  • InstitutionsMIXED

    Q2 2026: 9 added (0 new), 9 trimmed or exited.

  • AnalystsBULLISH

    9 of 11 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.120 → $0.040 over 90 days. 0 up, 1 down in 30 days.

  • TrendDOWNTREND

    12% below its 50-day average. New closing low $1.03 on Oct 21.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.NEAR_EXIT365,945$691.6K
GEODE CAPITAL MANAGEMENT, LLCTRIM260,488$492.6K
UBS Group AGDOUBLED244,224$461.6K
GOLDMAN SACHS GROUP INCDOUBLED215,384$407.1K
STATE STREET CORPNEAR_EXIT112,244$212.1K
JONES FINANCIAL COMPANIES LLLPDOUBLED111,605$199.8K
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED103,307$195.3K
NORTHERN TRUST CORPTRIM71,418$135.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 82% rate it Buy or better
Strong Buy3Buy6Hold2Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +117%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Aug 10, 2026B. Riley Securities
MAINTAIN
MAINTAINNeutral
Aug 7, 2026TD Cowen
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$202.2K
bought · 1 insider
$0
sold · 0 insiders
−25.0%
vs their $1.53 cost
DateInsiderTypeValue
Aug 11, 2026
Beer Marc D
Executive Chairman
BUY$24.8K
Aug 10, 2026
Beer Marc D
Executive Chairman
BUY$177.4K
Jun 12, 2026
Peterson Robert Charles
Interim CEO
AWARD206,746 sh
Jun 8, 2026
Beer Marc D
Executive Chairman
AWARD114,157 sh
Jun 8, 2026
Christensen Bret
Director
AWARD130,000 sh
May 12, 2026
HEYER ANDREW R
Director
AWARD130,000 sh
May 12, 2026
HEYER ANDREW R
Director
AWARD35,259 sh
May 12, 2026
Barrera Richard R
Director
AWARD121,452 sh

Earnings setup

Estimates
Nov 4
reports in 8 days
$0.04
EPS estimate, this quarter
−67%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.04$0.04–$0.04-66.7%$44.0M
Next Q🔒 Fresh data, subscribers only
Current FY$0.35$0.35–$0.35-28.6%$177.9M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 22, 2026 SEC
Institutional activity in biote Corp. (BTMD) during Q2 2026 was mixed: 9 small buyers accumulated $1.1M in new…
INST-CLUSTER — Impact 3/10
Sep 18, 2026 SEC
Amit Mohan Agarwal filed an amended Schedule 13G on 2026-09-18, reporting a passive stake of 2,400,000 shares (8.37%…
SC 13G/A — Impact 4/10
Aug 31, 2026 Short interest report
Short Interest: BTMD up 112% to 1.4M shares
Settlement 2026-08-31 | Days to cover: 3.41 | ≈3.88% of shares outstanding (est.)
Aug 11, 2026 Insider
Beer Marc D bought 16,000 shares
Executive Chairman @ $1.55 ($24.8K)
Aug 10, 2026 Insider
Beer Marc D bought 115,950 shares
Executive Chairman @ $1.53 ($177.4K)
Jun 30, 2026 Inst.
BlackRock, Inc. — NEAR_EXIT
365,945 shares ($691.6K)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
260,488 shares ($492.6K)
Jun 12, 2026 Insider
Peterson Robert Charles was granted 206,746 shares
Interim CEO
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
BTMD Q3 2026 Earnings Scheduled — 2026-11-04
Recent
Aug 31, 2026
Short interest
Short Interest: BTMD up 112% to 1.4M shares
Settlement 2026-08-31 | Days to cover: 3.41 | ≈3.88% of shares outstanding (est.)
Aug 5, 2026
Earnings date
BTMD Q2 2026 Earnings Scheduled — 2026-08-05
May 6, 2026
Earnings date
BTMD Q1 2026 Earnings Scheduled — 2026-05-06
Mar 11, 2026
Earnings date
BTMD Q4 2025 Earnings After Market Close — 2026-03-11

SecBot reports

4 filings · 0 bullish · 0 bearish · 4 neutral
All BTMD filing & press-release reports (4)